Payment overview · 2025
General Payments
$124.86
1 reported records · 1 companies
Healthcare provider profile · identity verified
Sangeetha Polasa, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · LONGWOOD, FL · NPI 1336107622
Verified facts
What the public records show
CMS Open Payments records show Sangeetha Polasa, M.D. received $124.86 in general payments during 2025 across 1 reported records.
Neurocrine BioSciences, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $124.86 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $124.86 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $124.86 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 590 | 101 |
| Eliquis | Apixaban | 515 | 41 |
| Gabapentin | Gabapentin | 439 | 67 |
| Levothyroxine Sodium | Levothyroxine Sodium | 416 | 55 |
| Amlodipine Besylate | Amlodipine Besylate | 366 | 70 |
| Furosemide | Furosemide | 316 | 45 |
| Tamsulosin Hcl | Tamsulosin Hcl | 278 | 44 |
| Carvedilol | Carvedilol | 263 | 45 |
| Clopidogrel | Clopidogrel Bisulfate | 262 | 40 |
| Potassium Chloride | Potassium Chloride | 259 | 54 |
| Mirtazapine | Mirtazapine | 241 | 52 |
| Losartan Potassium | Losartan Potassium | 236 | 40 |
| Metoprolol Tartrate | Metoprolol Tartrate | 228 | 46 |
| Donepezil Hcl | Donepezil Hcl | 224 | 27 |
| Sertraline Hcl | Sertraline Hcl | 181 | 29 |
| Xarelto | Rivaroxaban | 168 | suppressed |
| Pantoprazole Sodium | Pantoprazole Sodium | 167 | 36 |
| Hydralazine Hcl | Hydralazine Hcl | 152 | 30 |
| Famotidine | Famotidine | 141 | 29 |
| Trazodone Hcl | Trazodone Hcl | 137 | 34 |
| Buspirone Hcl | Buspirone Hcl | 132 | 19 |
| Lisinopril | Lisinopril | 124 | 30 |
| Escitalopram Oxalate | Escitalopram Oxalate | 120 | 20 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 120 | 35 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 118 | 16 |
| Metformin Hcl | Metformin Hcl | 117 | 21 |
| Baclofen | Baclofen | 111 | 28 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 108 | 14 |
| Quetiapine Fumarate | Quetiapine Fumarate | 99 | 14 |
| Levetiracetam | Levetiracetam | 98 | 14 |
| Lactulose | Lactulose | 97 | 19 |
| Latanoprost | Latanoprost | 97 | 19 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 96 | 31 |
| Ondansetron Hcl | Ondansetron Hcl | 96 | 33 |
| Memantine Hcl | Memantine Hcl | 93 | 13 |
| Sucralfate | Sucralfate | 84 | 12 |
| Divalproex Sodium | Divalproex Sodium | 83 | 17 |
| Doxycycline Hyclate | Doxycycline Hyclate | 83 | 43 |
| Duloxetine Hcl | Duloxetine Hcl | 80 | 14 |
| Montelukast Sodium | Montelukast Sodium | 79 | 11 |
| Alprazolam | Alprazolam | 74 | 14 |
| Omeprazole | Omeprazole | 73 | 14 |
| Metoprolol Succinate | Metoprolol Succinate | 71 | 17 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 70 | 28 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 66 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 66 | 19 |
| Clonidine Hcl | Clonidine Hcl | 65 | 19 |
| Entresto | Sacubitril/Valsartan | 64 | suppressed |
| Insulin Lispro | Insulin Lispro | 64 | 20 |
| Nystatin | Nystatin | 64 | 28 |
| Finasteride | Finasteride | 63 | 12 |
| Torsemide | Torsemide | 63 | 14 |
| Ceftriaxone | Ceftriaxone Sodium | 62 | 31 |
| Lorazepam | Lorazepam | 61 | 13 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 57 | suppressed |
| Jardiance | Empagliflozin | 57 | suppressed |
| Nifedipine Er | Nifedipine | 57 | 11 |
| Oxycodone Hcl | Oxycodone Hcl | 57 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 56 | 11 |
| Warfarin Sodium | Warfarin Sodium | 54 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 53 | 14 |
| Methocarbamol | Methocarbamol | 50 | 18 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 50 | 16 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 49 | suppressed |
| Trulicity | Dulaglutide | 49 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 47 | suppressed |
| Bumetanide | Bumetanide | 46 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 46 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 46 | 12 |
| Prednisone | Prednisone | 45 | 14 |
| Tradjenta | Linagliptin | 44 | suppressed |
| Cefdinir | Cefdinir | 42 | 23 |
| Namzaric | Memantine Hcl/Donepezil Hcl | 42 | suppressed |
| Pregabalin | Pregabalin | 42 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 41 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 39 | 25 |
| Gentamicin Sulfate | Gentamicin Sulfate | 38 | 12 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 38 | 14 |
| Tramadol Hcl | Tramadol Hcl | 38 | 19 |
| Timolol Maleate | Timolol Maleate | 37 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 36 | 12 |
| Glipizide | Glipizide | 36 | suppressed |
| Procrit | Epoetin Alfa | 36 | 11 |
| Januvia | Sitagliptin Phosphate | 34 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 33 | suppressed |
| Humalog | Insulin Lispro | 33 | 12 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 33 | suppressed |
| Klor-Con 10 | Potassium Chloride | 33 | suppressed |
| Ranolazine Er | Ranolazine | 32 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 31 | suppressed |
| Simvastatin | Simvastatin | 31 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 30 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 30 | 14 |
| Spironolactone | Spironolactone | 30 | 13 |
| Ezetimibe | Ezetimibe | 29 | suppressed |
| Allopurinol | Allopurinol | 28 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 28 | 11 |
| Cephalexin | Cephalexin | 28 | 16 |
| Sevelamer Hcl | Sevelamer Hcl | 28 | suppressed |
| Ketoconazole | Ketoconazole | 27 | 14 |
| Risperidone | Risperidone | 27 | suppressed |
| Vascepa | Icosapent Ethyl | 27 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 26 | 14 |
| Kapspargo Sprinkle | Metoprolol Succinate | 26 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 26 | 18 |
| Propranolol Hcl | Propranolol Hcl | 26 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 25 | 16 |
| Clonazepam | Clonazepam | 25 | suppressed |
| Xtampza Er | Oxycodone Myristate | 25 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Bicalutamide | Bicalutamide | 24 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 24 | 11 |
| Nitroglycerin | Nitroglycerin | 24 | 11 |
| Carbamazepine | Carbamazepine | 23 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 23 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 23 | suppressed |
| Lubiprostone | Lubiprostone | 23 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 23 | suppressed |
| Xifaxan | Rifaximin | 23 | suppressed |
| Fosfomycin Tromethamine | Fosfomycin Tromethamine | 22 | 18 |
| Amitriptyline Hcl | Amitriptyline Hcl | 21 | suppressed |
| Brilinta | Ticagrelor | 21 | suppressed |
| Trandolapril | Trandolapril | 21 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 20 | suppressed |
| Digoxin | Digoxin | 20 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 20 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 20 | suppressed |
| Lidocaine | Lidocaine | 20 | suppressed |
| Lovastatin | Lovastatin | 20 | suppressed |
| Ondansetron Odt | Ondansetron | 20 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 20 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 19 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 19 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 18 | suppressed |
| Hydrocortisone | Hydrocortisone | 18 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 18 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 18 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 17 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 17 | suppressed |
| Meropenem-0.9% Nacl | Meropenem-0.9% Sodium Chloride | 17 | suppressed |
| Pentoxifylline | Pentoxifylline | 17 | suppressed |
| Budesonide | Budesonide | 16 | suppressed |
| Glucagon Emergency Kit | Glucagon | 16 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 15 | suppressed |
| Azithromycin | Azithromycin | 15 | suppressed |
| Bupropion Xl | Bupropion Hcl | 15 | suppressed |
| Cilostazol | Cilostazol | 15 | suppressed |
| Glimepiride | Glimepiride | 15 | suppressed |
| Methotrexate | Methotrexate Sodium | 15 | suppressed |
| Olanzapine | Olanzapine | 15 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 15 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 15 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 15 | suppressed |
| Acetazolamide | Acetazolamide | 14 | suppressed |
| Fluconazole | Fluconazole | 14 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 14 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 14 | suppressed |
| Linezolid | Linezolid | 14 | suppressed |
| Meloxicam | Meloxicam | 14 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 14 | suppressed |
| Polymyxin B Sul-Trimethoprim | Polymyxin B Sulf/Trimethoprim | 14 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 13 | suppressed |
| Levofloxacin | Levofloxacin | 13 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 12 | suppressed |
| Cyclosporine | Cyclosporine | 12 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 12 | suppressed |
| Ertapenem | Ertapenem Sodium | 12 | suppressed |
| Insulin Aspart | Insulin Aspart | 12 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 12 | suppressed |
| Metolazone | Metolazone | 12 | suppressed |
| Novolog | Insulin Aspart | 12 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 12 | suppressed |
| Simbrinza | Brinzolamide/Brimonidine Tart | 12 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 12 | suppressed |
| Arformoterol Tartrate | Arformoterol Tartrate | 11 | suppressed |
| Dorzolamide-Timolol | Dorzolamide/Timolol/Pf | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 11 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 11 | suppressed |
| Nyamyc | Nystatin | 11 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 11 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 11 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 11 | suppressed |
| Vyzulta | Latanoprostene Bunod | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $124.86 · 1 records | Neurocrine BioSciences, Inc. | INGREZZA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error